<DOC>
	<DOC>NCT00250458</DOC>
	<brief_summary>Study to test the effectiveness of a marketed drug in the treatment of migraine-associated nausea.</brief_summary>
	<brief_title>Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>6month history of migraine, moderate to severe migraine attacks with nausea, 16 migraine attacks per month Heart disease, high blood pressure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>